ProCE Banner Activity

RSV Vaccines in Adults: A Risk-Based Approach

Podcast Episodes

Listen to Angela Branche, MD, share her perspective on why healthcare professionals should consider a risk-based approach—rather than age alone—to determine RSV vaccine candidacy in adults.

Released: December 27, 2023

Share

Faculty

Angela Branche

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Partners

Practicing Clinicians Exchange

ProCE Banner

Faculty Disclosure

Primary Author

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Angela Branche, MD: consultant/advisor/speaker: GlaxoSmithKline, Janssen; researcher: Cyanvac, Merck, Pfizer.